SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-22-105614
Filing Date
2022-10-04
Accepted
2022-10-04 08:56:45
Documents
4
Period of Report
2022-10-04

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2217325d5_6k.htm 6-K 17908
2 EXHIBIT 1.1 tm2217325d5_ex1-1.htm EX-1.1 311106
3 EXHIBIT 5.1 tm2217325d5_ex5-1.htm EX-5.1 30594
4 GRAPHIC tm2217325d5_ex5-1img01.jpg GRAPHIC 2545
  Complete submission text file 0001104659-22-105614.txt   364257
Mailing Address BREDGADE 34E COPENHAGEN K G7 1260
Business Address BREDGADE 34E COPENHAGEN K G7 1260 4531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 221289826
SIC: 2836 Biological Products, (No Diagnostic Substances)